Jyong Biotech PE Ratio 1971-1970 | MENS
Current and historical p/e ratio for Jyong Biotech (MENS) from 1971 to 1970. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Jyong Biotech PE ratio as of June 27, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Jyong Biotech PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 1999-06-01 | 11.13 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED-BIOMED/GENE | $0.693B | $0.000B |
| Jyong Biotech Ltd. is a science-driven biotechnology company. It involved in developing and commercializing new drugs mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. Jyong Biotech Ltd. is based in New Taipei City, Taiwan. | |||